This study aims to explore the potential targets and molecular mechanisms of COP in bladder bladder cancer through network pharmacology, molecular docking and molecular dynamics simulation, and validate the results of in silico analysis with in vitro assays, and further verify the tumor-suppressive properties of COP with animal models. The gene discussed is CARD16; the disease is urinary bladder cancer.